Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long noncoding RNA CARDINAL cis-activates MYOCD expression by recruiting histone reader ZZZ3 in vascular smooth muscle cell phenotype alteration.

Cardiovascular research·2026
Same author

Type of pledget and suture technique relative to esophageal tensile strength in long-gap esophageal atresia.

Pediatric surgery international·2026
Same author

A Multidimensional Digital Approach to Pain Assessment in Sickle Cell Disease: A Feasibility Study in Ghana.

Journal of pain research·2026
Same author

Impaired Taurine Transport Contributes to Bronchopulmonary Dysplasia: A Systems Biology Analysis.

American journal of respiratory cell and molecular biology·2026
Same author

NAD + -Boosting Ameliorates Heme Protein-Mediated Acute Kidney Injury.

Kidney360·2025
Same author

Autophagy modulates the mechanism of flow-mediated dilation upstream of telomerase.

Basic research in cardiology·2025

相关实验视频

Updated: Jul 11, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

L-4F是一种阿波利波蛋白A-1模仿物,在高胆固醇和状细胞疾病中显著改善血管扩张.

Jingsong Ou1, Zhijun Ou, Deron W Jones

  • 1Division of Pediatric Surgery, Department of Surgery, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA.

Circulation
|May 7, 2003
PubMed
概括
此摘要是机器生成的。

模仿阿波利波蛋白A-1的L-4F通过减少超氧化物生成,在高胆固醇血清和状细胞疾病中保持血管扩张. 这表示L-4F.

更多相关视频

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

相关实验视频

Last Updated: Jul 11, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

科学领域:

  • 血管生物学 血管生物学
  • 心血管研究研究心血管研究
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 高胆固醇血症和状细胞疾病 (SCD) 通过不同的机制破坏内皮依赖血管扩张.
  • 高胆固醇血症涉及低密度脂蛋白 (LDL) 依赖性损伤,而SCD是一种慢性炎症状态,通过丁氧化酶 (XO) 增加了血管超氧化 (O2 * -) 的产生.
  • 像L-4F这样的Apolipoprotein (apo) A-1模仿剂已经显示出抑制动脉样硬化的潜力.

研究的目的:

  • 通过减少增加O2*-生成的机制来研究L-4F在高胆固醇血症和SCD中保持血管扩张的假设.
  • 在高胆固醇和SCD模型中评估L-4F的疗效.

主要方法:

  • 从高胆固醇血的LDL受体-null (Ldlr-/-) 小鼠和用L-4F或盐水治疗的SCD小鼠中分离出的动脉.
  • 使用视频显微镜评估血管扩张.
  • 在动脉细分和内皮细胞中量化O2*-生成,分别使用乙定量和铁细胞染色体c减少.
  • 通过免疫光检测确定L-4F对肺动脉小动脉和肝脏组织中XO结合和含量的影响.

主要成果:

  • 在高胆固醇血的Ldlr-/-小鼠中,L-4F显著改善了受损的血管扩张.
  • 在动脉段和内皮细胞培养中,L-4F抑制了LDL诱导的O2*-生成的增加.
  • 在SCD小鼠中,L-4F改善了血管扩张,减少了与肺内皮结合的XO,并增加了与对照组相比肝脏的XO含量.

结论:

  • 在高胆固醇血症和SCD中,L-4F对内皮依赖血管扩张具有保护作用.
  • 这些发现表明,L-4F有可能在各种疾病模型中恢复血管内皮功能.
  • 对于各种血管疾病,L-4F可能是一个有前途的治疗剂.